The Importance of Confirming False Homozygosity in Pretransplant HLA Typing Results of Patients with Hematologic Malignancies
International Journal of Medical Sciences · 2024
DOI: 10.7150/ijms.99883 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Min Young Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Kyung Hee University College of Medicine and Kyung Hee University Hospital at Gangdong, Seoul, Korea. Hauptthemen laut MEDLINE: Histocompatibility Testing, Homozygote, Loss of Heterozygosity, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Kyung Hee University College of Medicine and Kyung Hee University Hospital at Gangdong, Seoul, Korea.
- Department of Laboratory Medicine, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea.
Zitieren
APA
Lee, M. Y., & You, E. (2024). The Importance of Confirming False Homozygosity in Pretransplant HLA Typing Results of Patients with Hematologic Malignancies. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.99883
Vancouver
Lee MY, You E. The Importance of Confirming False Homozygosity in Pretransplant HLA Typing Results of Patients with Hematologic Malignancies. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.99883
BibTeX
@article{Lee2024,
author = {Lee, Min Young and You, Eunkyoung},
title = {The Importance of Confirming False Homozygosity in Pretransplant HLA Typing Results of Patients with Hematologic Malignancies},
journal = {International Journal of Medical Sciences},
year = {2024},
doi = {10.7150/ijms.99883}
}
EUVIMED